Form 4: NeuroPace CEO Joel Becker Reports Stock Withholding

CEO Joel Becker reported the withholding of 1,126 shares of NeuroPace common stock to satisfy tax obligations related to RSU vesting.

Summary

• Joel Becker, CEO of NeuroPace Inc., executed a transaction on May 27, 2026.
• The transaction involved the withholding of 1,126 shares of common stock by the company.
• The shares were withheld at a price of $17.06 per share.
• The purpose of the transaction was to satisfy tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Following this transaction, the CEO maintains beneficial ownership of 141,691 shares of NeuroPace common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative tax transaction rather than a strategic or market-driven move.

Positives

• The transaction is a routine administrative action related to tax obligations upon RSU vesting, rather than a discretionary open-market sale.

Negatives

• The transaction results in a minor reduction in the total number of shares held directly by the CEO.

Risks

• None identified; this is a standard regulatory disclosure for executive compensation tax compliance.

Future Outlook

Not applicable; this is a historical disclosure of a completed transaction.

Industry Context

StockSavvy.ai notes that this filing is a standard regulatory requirement for corporate insiders and does not reflect a change in management's outlook or strategic direction for the company.

Comparison to Industry Standards

• The practice of withholding shares to satisfy tax obligations upon RSU vesting is a standard industry practice for publicly traded companies in the medical device and technology sectors.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard tax-related withholding.

Key Dates

Keywords

NeuroPace, NPCE, Form 4, Insider Trading, Executive Compensation, Tax Withholding